Bacasmas, Roel I.
HRN: 25-25-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/07/2024
06/13/2024
IV
600mg
Q8
Acute Tonsilopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes